TKNO
Alpha Teknova Inc
NASDAQ: TKNO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.55
+9.91% today
Updated 2026-04-30
Market cap
$175.31M
P/E ratio
—
P/S ratio
4.33x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$2 – $7
Volume
0.1M
Alpha Teknova Inc (TKNO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $20.09M | $31.30M | $36.89M | $41.42M | $36.68M | $37.74M | $40.52M |
| Revenue growth (YoY) | — | +55.8% | +17.9% | +12.3% | -11.4% | +2.9% | +7.4% |
| Cost of revenue | $11.52M | $13.54M | $19.27M | $23.94M | $26.39M | $30.51M | $27.08M |
| Gross profit | $8.57M | $17.75M | $17.62M | $17.48M | $10.30M | $7.23M | $13.44M |
| Gross margin | 42.7% | 56.7% | 47.8% | 42.2% | 28.1% | 19.2% | 33.2% |
| R&D | $769000.00 | $1.51M | $4.31M | $7.74M | $5.57M | $2.76M | $2.20M |
| SG&A | $7.63M | $8.21M | $20.39M | $28.30M | $25.45M | $23.15M | $20.32M |
| Operating income | $-1.86M | $4.66M | $-12.01M | $-49.66M | $-35.56M | $-26.15M | $-16.98M |
| Operating margin | -9.2% | 14.9% | -32.5% | -119.9% | -96.9% | -69.3% | -41.9% |
| EBITDA | $-233000.00 | $6.71M | $-9.13M | $-25.69M | $-25.54M | $-19.57M | $-10.15M |
| EBITDA margin | -1.2% | 21.4% | -24.7% | -62.0% | -69.6% | -51.8% | -25.0% |
| EBIT | $-1.86M | $4.66M | $-12.01M | $-28.86M | $-31.20M | $-26.15M | $-16.49M |
| Interest expense | $56000.00 | $63000.00 | $589000.00 | $213000.00 | $833000.00 | $687000.00 | $710000.00 |
| Income tax | $-495000.00 | $1.16M | $-2.83M | $-1.92M | $-298000.00 | $-88000.00 | — |
| Effective tax rate | 27.5% | 24.5% | 22.4% | 3.9% | 0.8% | 0.3% | 0.0% |
| Net income | $-1.30M | $3.57M | $-9.80M | $-47.47M | $-36.78M | $-26.75M | $-17.26M |
| Net income growth (YoY) | — | +373.6% | -374.6% | -384.2% | +22.5% | +27.3% | +35.5% |
| Profit margin | -6.5% | 11.4% | -26.6% | -114.6% | -100.3% | -70.9% | -42.6% |